Lung Cancer Assay

Phase II SBIR Contract to Epic Sciences for Development of Lung Cancer Blood Test
Jan 28, 2013
The National Cancer Institute (NCI) and the National Institutes of Health (NIH) have announced a Phase II small business innovation research (SBIR) contract to Epic Sciences for the development of a lung cancer diagnostic blood test. The ...

Tags: Lung Cancer Assay, lung cancer diagnostic, blood test